LEGN

Legend Biotech Stock Analysis

AI Rating

Low
  • Quality4/10
  • Growth↓ 3/10
  • Momentum↓ 1/10
Legend Biotech sales and earnings growth
LEGN Growth
Neutral
  • Revenue Y/Y↑ 74.74%
  • EPS Y/Y↑ 31.58%
  • FCF Y/Y↓ -10.03%
Legend Biotech gross and profit margin trends
LEGN Profitability
Neutral
  • Gross margin ↑ 60.60%
  • EPS margin↓ -26.40%
  • ROIC↓ -27.80%
Legend Biotech net debt vs free cash flow
LEGN Risk
Great
  • Debt / Equity↓ 0.4
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -9.6

Legend Biotech stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗